CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples.
about
Using biomarkers as objective standards in the diagnosis of cervical biopsies.Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women.Do clinical data and human papilloma virus genotype influence spontaneous regression in grade I cervical intraepithelial neoplasia?Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix.A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia.Impact of improved classification on the association of human papillomavirus with cervical precancer.Cervical histopathology variability among laboratories: a population-based statewide investigationHPV in HIV-Infected Women: Implications for Primary PreventionUpdated guidelines for papanicolaou tests, colposcopy, and human papillomavirus testing in adolescents.Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinantsHierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage studyThe role of co-factors in the progression from human papillomavirus infection to cervical cancerHPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions.Human papillomavirus testing in the prevention of cervical cancerPAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study.Triage of HR-HPV positive women with minor cytological abnormalities: a comparison of mRNA testing, HPV DNA testing, and repeat cytology using a 4-year follow-up of a population-based study.Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological AbnormalitiesNext Generation Cancer Protection: The Bivalent HPV Vaccine for FemalesThe clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy.Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasmTriage of Atypical Glandular Cell by SOX1 and POU4F3 Methylation: A Taiwanese Gynecologic Oncology Group (TGOG) StudyMinor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type.Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCMPrevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa RicaTriage of high-risk human papillomavirus-positive women by methylated POU4F3.The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test.Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: At which step of multistage carcinogenesis?HPV vaccines and cancer prevention, science versus activism.HPV immunisation and cervical screening--confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study.Location and Density of Immune Cells in Precursor Lesions and Cervical Cancer.Six-year regression and progression of cervical lesions of different human papillomavirus viral loads in varied histological diagnoses.HPV-Based Screening, Triage, Treatment, and Followup Strategies in the Management of Cervical Intraepithelial Neoplasia.Risk factors for persistent cervical intraepithelial neoplasia grades 1 and 2: managed by watchful waitingEvidence for frequent regression of cervical intraepithelial neoplasia-grade 2Cancer registries and monitoring the impact of prophylactic human papillomavirus vaccines: the potential role.Age-appropriate use of human papillomavirus vaccines in the U.S.Review: optical micrometer resolution scanning for non-invasive grading of precancer in the human uterine cervix.A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination.
P2860
Q30431203-B3035756-2E52-46BE-8A30-494143EA26E4Q33698774-59215F48-4778-410A-9C12-DFECF272CA16Q33728067-56D32CF7-8085-4BB0-B7F8-67157B37E53CQ33743070-5B6C4B59-067A-4B5F-8FC7-3C78FE3922DBQ33745439-78E34B3F-EADF-4CD5-8132-EDD8FBEA8592Q33793914-EE4C3C59-5C27-445F-9448-0795A1B019B3Q33883581-2B024FE5-9EB9-440D-85FE-6F8EB1A7371EQ34017556-272CACB2-35BB-4EC1-8655-F7D78FF0EE87Q34033445-833AACBF-DD7E-4A71-969A-43F8A5908D5AQ34121746-548CBA78-5201-4FB4-A0A3-71E534D470E1Q34187446-1114F1C1-64D0-45D0-B769-3BC2432F3829Q34268415-70642D5E-B847-4FCC-A053-FC3939994FA2Q34311313-8D0A72AD-D4DA-4EA6-A108-9BC18324DC5EQ34535660-A0F3808D-F86E-4ACD-AAEE-506B01B22DFAQ34616083-CEB9668A-3C9E-43CF-AAB6-80A614DB4E8CQ35000542-DB040C51-2311-46DD-B3DA-BF6FB48BB650Q35108590-B3A26A43-0E71-4764-9DA7-D97212517C25Q35498040-8BDBCED6-33F6-4540-BBE4-6AA3A29C17BEQ35550810-1AE5A390-E854-403C-AC9E-10FBDA10BFD2Q35588255-E11B6D4F-2A6E-49CB-BEED-759A4A575EE9Q35634408-26A816D6-9341-4FA2-AAEE-F98323CB38A7Q35658404-8AA3CAF0-9666-4EF6-A21A-D1A66CC639C8Q35665790-0208C890-DBBB-4525-A0C6-2F9AE5C4EACFQ35811067-2C9F7E76-1AD7-483F-84B8-5B94187BE733Q35967430-880B9CE3-A7CE-4D50-8CB0-21006EA88CDEQ35986654-B18BCAAD-DF02-4BF6-86E6-D88B2063608DQ36029632-3C70EBC7-6860-437B-99FC-0C3A77938219Q36159360-5E702DD4-CC33-46DA-BC63-EAA2C074BCAEQ36262929-09662A5E-C9F0-4C01-A929-F667847FF038Q36591743-AF5A3846-8FB1-491C-AB78-AFBABFF9F80DQ36662008-31750F6F-A009-4BA3-AEC4-2B7C1A5697B3Q36695065-DCA7912A-6943-4E5E-B4BE-176D0A1C343FQ36794559-E5111EA8-2478-464C-B4F5-6BF3BC87E333Q36830943-D25B8080-75DD-4F0A-8669-20B04AB73901Q36840427-9681E61F-904A-4420-8ED5-5D161ECEF71FQ37223672-40EF81F8-D619-4589-8538-16B093BCE49FQ37312127-DCE8E531-AE03-47CF-833B-BC798201D05BQ37312746-C6857D75-81D4-430E-83AE-BBA2CEE9E466Q37338131-35747465-02A9-45B2-817C-40ECD5397B4BQ37366649-16FE3F02-40AF-4468-8A56-B593EBC07BD9
P2860
CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
CIN2 is a much less reproducib ...... lation-based cervical samples.
@en
type
label
CIN2 is a much less reproducib ...... lation-based cervical samples.
@en
prefLabel
CIN2 is a much less reproducib ...... lation-based cervical samples.
@en
P2093
P50
P1476
CIN2 is a much less reproducib ...... lation-based cervical samples.
@en
P2093
Diane Solomon
Diego Guillén
Jorge Morales
Jose Jerónimo
Joseph D Carreon
Mark E Sherman
Martha Hutchinson
Robert D Burk
Rolando Herrero
P304
P356
10.1097/PGP.0B013E31805152AB
P577
2007-10-01T00:00:00Z